IDiyas

For the Inventor, By the Inventor

The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Patent No.:

US 9655883 B1

PDFFull Text
Date of Patent:
May. 23, 2017

Filed:

Jul. 12, 2010

Pharmaceutical composition

Applicant:

David Nigel Armstrong, Atlanta, GA (US);

Inventor:

David Nigel Armstrong, Atlanta, GA (US);

Assignee:

SLA PHARMA AG, , CH;

Attorneys:

Marianne Fuierer

Moore & Van Allen, PLLC

Primary Examiner:

Layla Soroush

Int. Cl.
CPC ...
A01N 45/00 (2006.01); A61K 31/56 (2006.01); A61K 31/4164 (2006.01); A61K 9/00 (2006.01); A61K 31/192 (2006.01); A61K 31/24 (2006.01); A61K 31/245 (2006.01); A61K 31/355 (2006.01); A61K 31/407 (2006.01); A61K 31/4166 (2006.01); A61K 31/545 (2006.01); A61K 31/573 (2006.01); A61K 31/60 (2006.01); A61K 31/65 (2006.01); A61K 33/30 (2006.01); A61K 45/06 (2006.01); A61K 47/06 (2006.01); A61K 47/44 (2017.01); A61K 9/06 (2006.01);
U.S. Cl.
CPC ...
A61K 31/4164 (2013.01); A61K 9/0014 (2013.01); A61K 9/0031 (2013.01); A61K 9/06 (2013.01); A61K 31/192 (2013.01); A61K 31/24 (2013.01); A61K 31/245 (2013.01); A61K 31/355 (2013.01); A61K 31/407 (2013.01); A61K 31/4166 (2013.01); A61K 31/545 (2013.01); A61K 31/573 (2013.01); A61K 31/60 (2013.01); A61K 31/65 (2013.01); A61K 33/30 (2013.01); A61K 45/06 (2013.01); A61K 47/06 (2013.01); A61K 47/44 (2013.01);
Abstract

A topical composition comprises at least 5-wt % metronidazole or a pharmacologically acceptable derivative thereof in a non-aqueous vehicle. The composition may be used in the treatment of conditions of the colon, rectum, anorectum and perianal region, in particular inflammatory bowel disease and perianal Crohn's disease. The composition also relieves pain and inflammation and promotes healing of the colon, rectum, and anorectum and perianal region following surgical operations. One advantage of the composition is that topical administration of metronidazole results in a primarily local effect and thus side effects observed from systemic administration are avoided.

Find Patent Forward Citations

Loading…